CN114868857A - Ginger and momordica grosvenori solid beverage and preparation method thereof - Google Patents
Ginger and momordica grosvenori solid beverage and preparation method thereof Download PDFInfo
- Publication number
- CN114868857A CN114868857A CN202210642823.9A CN202210642823A CN114868857A CN 114868857 A CN114868857 A CN 114868857A CN 202210642823 A CN202210642823 A CN 202210642823A CN 114868857 A CN114868857 A CN 114868857A
- Authority
- CN
- China
- Prior art keywords
- momordica grosvenori
- ginger
- extract
- solid beverage
- parts
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 235000011171 Thladiantha grosvenorii Nutrition 0.000 title claims abstract description 62
- 235000006886 Zingiber officinale Nutrition 0.000 title claims abstract description 60
- 235000008397 ginger Nutrition 0.000 title claims abstract description 60
- 235000013361 beverage Nutrition 0.000 title claims abstract description 42
- 239000007787 solid Substances 0.000 title claims abstract description 42
- 238000002360 preparation method Methods 0.000 title claims abstract description 18
- 244000185386 Thladiantha grosvenorii Species 0.000 title claims abstract 15
- 244000273928 Zingiber officinale Species 0.000 title claims description 5
- 241000234314 Zingiber Species 0.000 claims abstract description 57
- 239000000284 extract Substances 0.000 claims abstract description 43
- 102000008186 Collagen Human genes 0.000 claims abstract description 25
- 108010035532 Collagen Proteins 0.000 claims abstract description 25
- 229920001436 collagen Polymers 0.000 claims abstract description 25
- FTSSQIKWUOOEGC-RULYVFMPSA-N fructooligosaccharide Chemical compound OC[C@H]1O[C@@](CO)(OC[C@@]2(OC[C@@]3(OC[C@@]4(OC[C@@]5(OC[C@@]6(OC[C@@]7(OC[C@@]8(OC[C@@]9(OC[C@@]%10(OC[C@@]%11(O[C@H]%12O[C@H](CO)[C@@H](O)[C@H](O)[C@H]%12O)O[C@H](CO)[C@@H](O)[C@@H]%11O)O[C@H](CO)[C@@H](O)[C@@H]%10O)O[C@H](CO)[C@@H](O)[C@@H]9O)O[C@H](CO)[C@@H](O)[C@@H]8O)O[C@H](CO)[C@@H](O)[C@@H]7O)O[C@H](CO)[C@@H](O)[C@@H]6O)O[C@H](CO)[C@@H](O)[C@@H]5O)O[C@H](CO)[C@@H](O)[C@@H]4O)O[C@H](CO)[C@@H](O)[C@@H]3O)O[C@H](CO)[C@@H](O)[C@@H]2O)[C@@H](O)[C@@H]1O FTSSQIKWUOOEGC-RULYVFMPSA-N 0.000 claims abstract description 24
- 229940107187 fructooligosaccharide Drugs 0.000 claims abstract description 24
- 108090000765 processed proteins & peptides Proteins 0.000 claims abstract description 24
- 239000002994 raw material Substances 0.000 claims abstract description 10
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 28
- 229920002774 Maltodextrin Polymers 0.000 claims description 18
- 239000005913 Maltodextrin Substances 0.000 claims description 18
- 229940035034 maltodextrin Drugs 0.000 claims description 18
- 229940002508 ginger extract Drugs 0.000 claims description 17
- 235000020708 ginger extract Nutrition 0.000 claims description 17
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 17
- 239000004376 Sucralose Substances 0.000 claims description 15
- BAQAVOSOZGMPRM-QBMZZYIRSA-N sucralose Chemical compound O[C@@H]1[C@@H](O)[C@@H](Cl)[C@@H](CO)O[C@@H]1O[C@@]1(CCl)[C@@H](O)[C@H](O)[C@@H](CCl)O1 BAQAVOSOZGMPRM-QBMZZYIRSA-N 0.000 claims description 15
- 235000019408 sucralose Nutrition 0.000 claims description 15
- 235000009815 Momordica Nutrition 0.000 claims description 13
- 241000218984 Momordica Species 0.000 claims description 13
- 235000013399 edible fruits Nutrition 0.000 claims description 13
- 239000000463 material Substances 0.000 claims description 13
- 235000003599 food sweetener Nutrition 0.000 claims description 12
- 239000003765 sweetening agent Substances 0.000 claims description 12
- 238000002156 mixing Methods 0.000 claims description 7
- 239000008213 purified water Substances 0.000 claims description 7
- 238000001694 spray drying Methods 0.000 claims description 7
- 229930182470 glycoside Natural products 0.000 claims description 5
- 150000002338 glycosides Chemical class 0.000 claims description 5
- 239000001841 zingiber officinale Substances 0.000 claims description 4
- 238000004821 distillation Methods 0.000 claims description 2
- 239000000469 ethanolic extract Substances 0.000 claims description 2
- 238000004806 packaging method and process Methods 0.000 claims description 2
- 208000031975 Yang Deficiency Diseases 0.000 abstract description 11
- 210000003734 kidney Anatomy 0.000 abstract description 10
- 239000003814 drug Substances 0.000 abstract description 8
- 230000000694 effects Effects 0.000 abstract description 7
- 235000013305 food Nutrition 0.000 abstract description 7
- 210000000952 spleen Anatomy 0.000 abstract description 6
- 210000002784 stomach Anatomy 0.000 abstract description 6
- 229940079593 drug Drugs 0.000 abstract description 4
- 241000721047 Danaus plexippus Species 0.000 abstract description 2
- 241001409321 Siraitia grosvenorii Species 0.000 description 54
- 241000700159 Rattus Species 0.000 description 17
- 230000000052 comparative effect Effects 0.000 description 11
- 238000010298 pulverizing process Methods 0.000 description 10
- 239000013598 vector Substances 0.000 description 8
- 230000007914 freezing tolerance Effects 0.000 description 5
- 210000004072 lung Anatomy 0.000 description 5
- 239000012043 crude product Substances 0.000 description 4
- 238000011156 evaluation Methods 0.000 description 4
- 230000001953 sensory effect Effects 0.000 description 4
- GHBNZZJYBXQAHG-KUVSNLSMSA-N (2r,3r,4s,5s,6r)-2-[[(2r,3s,4s,5r,6r)-6-[[(3s,8s,9r,10r,11r,13r,14s,17r)-17-[(2r,5r)-5-[(2s,3r,4s,5s,6r)-4,5-dihydroxy-3-[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-6-[[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy Chemical compound C([C@H]1O[C@H]([C@@H]([C@@H](O)[C@@H]1O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)O[C@H](CC[C@@H](C)[C@@H]1[C@]2(C[C@@H](O)[C@@]3(C)[C@H]4C(C([C@@H](O[C@H]5[C@@H]([C@@H](O)[C@H](O)[C@@H](CO[C@H]6[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O6)O)O5)O)CC4)(C)C)=CC[C@H]3[C@]2(C)CC1)C)C(C)(C)O)O[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O GHBNZZJYBXQAHG-KUVSNLSMSA-N 0.000 description 3
- 230000002950 deficient Effects 0.000 description 3
- 206010016256 fatigue Diseases 0.000 description 3
- 238000000034 method Methods 0.000 description 3
- TVJXHJAWHUMLLG-UHFFFAOYSA-N mogroside V Natural products CC(CCC(OC1OC(COC2OC(CO)C(O)C(O)C2OC3OC(CO)C(O)C(O)C3O)C(O)C(O)C1O)C(C)(C)O)C4CCC5(C)C6CC=C7C(CCC(OC8OC(COC9OC(CO)C(O)C(O)C9O)C(O)C(O)C8O)C7(C)C)C6(C)C(O)CC45C TVJXHJAWHUMLLG-UHFFFAOYSA-N 0.000 description 3
- 206010010774 Constipation Diseases 0.000 description 2
- 206010011224 Cough Diseases 0.000 description 2
- 239000004480 active ingredient Substances 0.000 description 2
- JYGXADMDTFJGBT-VWUMJDOOSA-N hydrocortisone Chemical compound O=C1CC[C@]2(C)[C@H]3[C@@H](O)C[C@](C)([C@@](CC4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 JYGXADMDTFJGBT-VWUMJDOOSA-N 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- 238000010792 warming Methods 0.000 description 2
- LDXJRKWFNNFDSA-UHFFFAOYSA-N 2-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)-1-[4-[2-[[3-(trifluoromethoxy)phenyl]methylamino]pyrimidin-5-yl]piperazin-1-yl]ethanone Chemical compound C1CN(CC2=NNN=C21)CC(=O)N3CCN(CC3)C4=CN=C(N=C4)NCC5=CC(=CC=C5)OC(F)(F)F LDXJRKWFNNFDSA-UHFFFAOYSA-N 0.000 description 1
- IHCCLXNEEPMSIO-UHFFFAOYSA-N 2-[4-[2-(2,3-dihydro-1H-inden-2-ylamino)pyrimidin-5-yl]piperidin-1-yl]-1-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)ethanone Chemical compound C1C(CC2=CC=CC=C12)NC1=NC=C(C=N1)C1CCN(CC1)CC(=O)N1CC2=C(CC1)NN=N2 IHCCLXNEEPMSIO-UHFFFAOYSA-N 0.000 description 1
- YJLUBHOZZTYQIP-UHFFFAOYSA-N 2-[5-[2-(2,3-dihydro-1H-inden-2-ylamino)pyrimidin-5-yl]-1,3,4-oxadiazol-2-yl]-1-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)ethanone Chemical compound C1C(CC2=CC=CC=C12)NC1=NC=C(C=N1)C1=NN=C(O1)CC(=O)N1CC2=C(CC1)NN=N2 YJLUBHOZZTYQIP-UHFFFAOYSA-N 0.000 description 1
- YLZOPXRUQYQQID-UHFFFAOYSA-N 3-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)-1-[4-[2-[[3-(trifluoromethoxy)phenyl]methylamino]pyrimidin-5-yl]piperazin-1-yl]propan-1-one Chemical compound N1N=NC=2CN(CCC=21)CCC(=O)N1CCN(CC1)C=1C=NC(=NC=1)NCC1=CC(=CC=C1)OC(F)(F)F YLZOPXRUQYQQID-UHFFFAOYSA-N 0.000 description 1
- DFGKGUXTPFWHIX-UHFFFAOYSA-N 6-[2-[4-[2-(2,3-dihydro-1H-inden-2-ylamino)pyrimidin-5-yl]piperazin-1-yl]acetyl]-3H-1,3-benzoxazol-2-one Chemical compound C1C(CC2=CC=CC=C12)NC1=NC=C(C=N1)N1CCN(CC1)CC(=O)C1=CC2=C(NC(O2)=O)C=C1 DFGKGUXTPFWHIX-UHFFFAOYSA-N 0.000 description 1
- 206010002953 Aphonia Diseases 0.000 description 1
- 206010063659 Aversion Diseases 0.000 description 1
- 206010010356 Congenital anomaly Diseases 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- AFCARXCZXQIEQB-UHFFFAOYSA-N N-[3-oxo-3-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)propyl]-2-[[3-(trifluoromethoxy)phenyl]methylamino]pyrimidine-5-carboxamide Chemical compound O=C(CCNC(=O)C=1C=NC(=NC=1)NCC1=CC(=CC=C1)OC(F)(F)F)N1CC2=C(CC1)NN=N2 AFCARXCZXQIEQB-UHFFFAOYSA-N 0.000 description 1
- 206010030113 Oedema Diseases 0.000 description 1
- 206010068319 Oropharyngeal pain Diseases 0.000 description 1
- 201000007100 Pharyngitis Diseases 0.000 description 1
- 241000700157 Rattus norvegicus Species 0.000 description 1
- 206010041497 Spermatorrhoea Diseases 0.000 description 1
- 206010042727 Swollen tongue Diseases 0.000 description 1
- 206010047700 Vomiting Diseases 0.000 description 1
- 210000000683 abdominal cavity Anatomy 0.000 description 1
- 230000003187 abdominal effect Effects 0.000 description 1
- 239000006286 aqueous extract Substances 0.000 description 1
- 208000006673 asthma Diseases 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 230000001143 conditioned effect Effects 0.000 description 1
- 235000009508 confectionery Nutrition 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 208000017574 dry cough Diseases 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 230000007661 gastrointestinal function Effects 0.000 description 1
- 238000003304 gavage Methods 0.000 description 1
- 229930182478 glucoside Natural products 0.000 description 1
- 150000008131 glucosides Chemical class 0.000 description 1
- 210000002216 heart Anatomy 0.000 description 1
- 229960000890 hydrocortisone Drugs 0.000 description 1
- 230000003301 hydrolyzing effect Effects 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 210000002429 large intestine Anatomy 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 239000013642 negative control Substances 0.000 description 1
- 206010029446 nocturia Diseases 0.000 description 1
- 238000005457 optimization Methods 0.000 description 1
- 235000013406 prebiotics Nutrition 0.000 description 1
- 206010036596 premature ejaculation Diseases 0.000 description 1
- 239000006041 probiotic Substances 0.000 description 1
- 235000018291 probiotics Nutrition 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 230000035755 proliferation Effects 0.000 description 1
- 239000011347 resin Substances 0.000 description 1
- 229920005989 resin Polymers 0.000 description 1
- 230000000717 retained effect Effects 0.000 description 1
- 230000001568 sexual effect Effects 0.000 description 1
- 208000011726 slow pulse Diseases 0.000 description 1
- 235000019654 spicy taste Nutrition 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 230000001502 supplementing effect Effects 0.000 description 1
- 230000004083 survival effect Effects 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 230000009466 transformation Effects 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/385—Concentrates of non-alcoholic beverages
- A23L2/39—Dry compositions
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
- A23L33/18—Peptides; Protein hydrolysates
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/20—Reducing nutritive value; Dietetic products with reduced nutritive value
- A23L33/21—Addition of substantially indigestible substances, e.g. dietary fibres
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/702—Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/42—Cucurbitaceae (Cucumber family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/906—Zingiberaceae (Ginger family)
- A61K36/9068—Zingiber, e.g. garden ginger
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/39—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin, cold insoluble globulin [CIG]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/331—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation, decoction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/333—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using mixed solvents, e.g. 70% EtOH
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/50—Methods involving additional extraction steps
- A61K2236/51—Concentration or drying of the extract, e.g. Lyophilisation, freeze-drying or spray-drying
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Nutrition Science (AREA)
- Mycology (AREA)
- Epidemiology (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Botany (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Alternative & Traditional Medicine (AREA)
- Biotechnology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medical Informatics (AREA)
- Microbiology (AREA)
- Molecular Biology (AREA)
- Toxicology (AREA)
- Gastroenterology & Hepatology (AREA)
- Immunology (AREA)
- Zoology (AREA)
- Biomedical Technology (AREA)
- Urology & Nephrology (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
The invention discloses a ginger and momordica grosvenori solid beverage and a preparation method thereof, and relates to the technical field of food and health-care food. The raw materials for preparing the ginger-momordica grosvenori solid beverage comprise dried ginger and momordica grosvenori or extracts thereof. The ginger and fructus momordicae solid beverage disclosed by the invention takes extracts of the dried ginger and the fructus momordicae as monarch drugs, has the effects of invigorating yang and nourishing yin, and takes fructo-oligosaccharide and collagen peptide as auxiliary drugs, so as to regulate spleen and stomach, moisten dryness, tonify qi and nourish yin. The ginger and fructus momordicae solid beverage is suitable for sub-health people or people with slight kidney-yang deficiency, warms and tonifies kidney yang, and tonifies but does not dry.
Description
Technical Field
The invention belongs to the technical field of food and health-care food, and particularly relates to a ginger and momordica grosvenori solid beverage and a preparation method thereof.
Background
Kidney yang deficiency is a type of symptoms caused by kidney yang deficiency, loss of warm-up, failure of qi transformation, and is usually caused by congenital deficiency, acquired fatigue or sexual intercourse. These patients often manifest themselves as lassitude, fatigue, aversion to cold, cold limbs, clear and profuse urine, frequent nocturia, spermatorrhea and premature ejaculation in males, difficulty in conception due to cold womb in females, pale and swollen tongue with white coating, deep and slow pulse, and weakness. The patients often have edema, mostly manifested as swelling of the lower part of the waist, which is difficult to cure.
Modern people have large long-term pressure and are in a sub-healthy state, and slight kidney-yang deficiency easily occurs. The traditional Chinese medicine for warming and invigorating kidney yang is applied, but the problems that yin and yang are unbalanced due to excessive yang tonifying, internal dryness and heat are caused, and body qi is lost easily occur.
Disclosure of Invention
Aiming at the problems, the invention provides a medicine and food dual-purpose dried ginger yang-tonifying component for warming and tonifying, and meanwhile, the dried ginger is matched with a food material fructus momordicae for moistening, so that excessive yang-tonifying is prevented. And the non-traditional components of fructo-oligosaccharide and collagen peptide are added to regulate the qi of the spleen and the stomach, thereby fundamentally supplementing the primordial yang.
Dried ginger
[ CHARACTER, WEI AND GUIJING ] is pungent and hot. It enters spleen, stomach, kidney, heart and lung meridians.
[ FUNCTIONS AND INDICATIONS ] can warm the middle-jiao to dispel cold, restore yang to activate collaterals, warm the lung and resolve retained fluid. Can be used for treating abdominal psychroalgia, emesis, diarrhea, cold limbs, slight pulse, cough and asthma due to cold fluid retention.
Momordica grosvenori
[ PROPERTIES AND FLAVOUR GUIDING CHANNEL ] is sweet and cool. It enters lung and large intestine meridians.
[ FUNCTIONS AND INDICATIONS ] can clear heat, moisten lung, relieve sore throat, restore voice, smooth intestines and relieve constipation. Can be used for treating lung heat dry cough, pharyngalgia aphonia, intestinal dryness constipation.
The fructo-oligosaccharide belongs to one of prebiotics, and can promote proliferation of probiotics and improve gastrointestinal function. From the perspective of traditional Chinese medicine, the Chinese medicine can tonify spleen and stomach, and tonify kidney to arrest seminal emission. Can regulate qi of spleen and stomach and fundamentally promote the balance of yin and yang of liver and kidney of human body.
The collagen peptide is prepared by hydrolyzing fresh animal tissues such as skin and bone rich in collagen as raw materials, and has effects of moistening dryness, invigorating qi, and nourishing yin.
In addition, the momordica grosvenori can also improve the spicy taste of the dried ginger.
The first aspect of the invention discloses a ginger and momordica grosvenori solid beverage, which is prepared from at least dried ginger and momordica grosvenori or extracts thereof, and preferably further comprises fructo-oligosaccharide, collagen peptide and sweetener.
In some preferred embodiments of the present invention, the weight ratio of the dried ginger to the momordica grosvenori is (50-60): (20-35), preferably (50-55): (30-35).
In some preferred embodiments of the present invention, the composition comprises the following raw materials in parts by weight:
50-60 parts of dried ginger extract, 20-35 parts of momordica grosvenori extract, 1-5 parts of fructo-oligosaccharide, 0.01-0.5 part of collagen peptide, 5-30 parts of auxiliary material maltodextrin and 0.05-0.2 part of sweetening agent.
In some preferred embodiments of the present invention, the dried ginger extract is an ethanol extract of dried ginger.
In some preferred embodiments of the present invention, the luo han guo extract is an aqueous extract of luo han guo.
In some preferred embodiments of the present invention, the luo han guo is a crude luo han guo glycoside V.
The second aspect of the invention discloses a preparation method of the ginger-momordica grosvenori solid beverage, which is characterized by comprising the following steps:
s01, preparing a dried ginger extract;
s02, preparing a fructus momordicae extract;
s03, adding fructo-oligosaccharide, collagen peptide, maltodextrin and sucralose, mixing, and packaging.
In some preferred embodiments of the present invention, in S01, the dried ginger is pulverized, and then 70-80% ethanol is added in an amount of 5-15 times the volume of the pulverized dried ginger, and the mixture is extracted at 40-60 ℃ for 3-5 hours, and the ethanol and water are removed by distillation under reduced pressure.
In some preferred embodiments of the present invention, in S02, the momordica grosvenori is taken, pulverized, added with purified water in an amount of 5-15 times the volume of the pulverized momordica grosvenori, and extracted at 40-60 ℃ for 3-5 hours; distilling the extractive solution under reduced pressure, concentrating to 1.4-1.5g/ml, and spray drying.
In some preferred embodiments of the present invention, the effect of the extract weight ratio of zingiber officinale and luo han guo on the freezing tolerance time of the resulting ginger luo han guo solid beverage in kidney yang deficient rats is optimized by:
s11, preparing at least 3 ginger and momordica grosvenori solid beverages with different weights of the ginger and the momordica grosvenori according to the weight ratio of the extracts of the ginger and the momordica grosvenori, namely 1:1, 1.5:1, 2:1, 2.5:1, 3.5:1, 4:1 and 5: 1;
s12, starting from the first proportion, vectors X1 and X2 respectively represent the average degree of the freeze-resisting time of the ginger-momordica grosvenori solid beverage obtained by the extract proportions of two adjacent dried gingers and momordica grosvenori to rats with kidney-yang deficiency;
s22, calculating the stability of the vector using the following formula:
Wherein, the first and the second end of the pipe are connected with each other,
s24, ifAnd if the weight ratio is more than 3.05, judging that the extract ratios of the two adjacent dried gingers and the momordica grosvenori have a significant difference, continuing to compare the next group by taking the second ratio as the start of the extract ratio of the two adjacent dried gingers and the momordica grosvenori until no significant difference exists, and taking the first weight ratio of the extract ratios of the two adjacent dried gingers and the momordica grosvenori as the optimal ratio.
The invention has the beneficial effects that:
the ginger-momordica grosvenori solid beverage disclosed by the invention adopts food raw materials, extracts of the dried ginger and the momordica grosvenori are used as monarch drugs, the extract has the effects of invigorating yang and nourishing yin, and fructo-oligosaccharide and collagen peptide are used as auxiliary drugs, so that the spleen and stomach are conditioned, dryness is moistened, qi is replenished, and yin is nourished. The ginger-momordica grosvenori solid beverage is suitable for sub-health people or people with slight kidney-yang deficiency, and can warm and tonify kidney yang without dryness.
The ginger-momordica grosvenori solid beverage can obviously improve the freezing tolerance time of rats with kidney-yang deficiency.
In the preparation process of the ginger-momordica grosvenori solid beverage, the active ingredient extracted from momordica grosvenori is found to be a momordica grosvenori glucoside V crude product.
Detailed Description
The embodiments of the present invention are described below with reference to specific embodiments, and other advantages and effects of the present invention will be easily understood by those skilled in the art from the disclosure of the present specification. The invention is capable of other and different embodiments and of being practiced or of being carried out in various ways, and its several details are capable of modification in various respects, all without departing from the spirit and scope of the present invention.
The dried ginger, the momordica grosvenori, the fructo-oligosaccharide, the collagen peptide, the maltodextrin and the sucralose are all commercially available products.
Unless otherwise specified, the examples and comparative examples are parallel tests with the same components, component contents, preparation steps, preparation parameters.
Example 1
A solid beverage containing ginger and momordica grosvenori is prepared from 50 parts of dried ginger extract, 35 parts of momordica grosvenori extract, 3.5 parts of fructo-oligosaccharide, 0.2 part of collagen peptide, 15 parts of auxiliary material maltodextrin and 0.08 part of sweetener sucralose.
The preparation method comprises the following steps:
(1) pulverizing Zingiberis rhizoma, adding 10 times volume of 75% ethanol, extracting at 50 deg.C for 4 hr, and distilling under reduced pressure to remove ethanol and water;
(2) pulverizing fructus Siraitiae Grosvenorii, adding 10 times of purified water, and extracting at 50 deg.C for 4 hr; distilling the extractive solution under reduced pressure, concentrating to 1.4-1.5g/ml, and spray drying;
(3) and (3) taking the dried ginger extract and the momordica grosvenori extract, adding fructo-oligosaccharide, collagen peptide, maltodextrin and sucralose, mixing, and subpackaging.
Example 2
A solid beverage containing ginger and grosvenor momordica fruit is prepared from dried ginger extract 50 parts, grosvenor momordica fruit extract 30 parts, fructo-oligosaccharide 3.5 parts, collagen peptide 0.2 part, auxiliary material maltodextrin 20 parts, and sweetening agent sucralose 0.08 part.
The preparation method comprises the following steps:
(1) pulverizing Zingiberis rhizoma, adding 10 times volume of 75% ethanol, extracting at 50 deg.C for 4 hr, and distilling under reduced pressure to remove ethanol and water;
(2) pulverizing fructus Siraitiae Grosvenorii, adding 10 times of purified water, and extracting at 50 deg.C for 4 h; distilling the extractive solution under reduced pressure, concentrating to 1.4-1.5g/ml, and spray drying;
(3) and (3) taking the dried ginger extract and the momordica grosvenori extract, adding fructo-oligosaccharide, collagen peptide, maltodextrin and sucralose, mixing, and subpackaging.
Example 3
The ginger-momordica grosvenori solid beverage is prepared from 55 parts of a dried ginger extract, 35 parts of a momordica grosvenori extract, 3.5 parts of fructo-oligosaccharide, 0.2 part of collagen peptide, 10 parts of auxiliary material maltodextrin and 0.08 part of sweetener sucralose.
The preparation method comprises the following steps:
(1) pulverizing Zingiberis rhizoma, adding 10 times volume of 75% ethanol, extracting at 50 deg.C for 4 hr, and distilling under reduced pressure to remove ethanol and water;
(2) pulverizing fructus Siraitiae Grosvenorii, adding 10 times of purified water, and extracting at 50 deg.C for 4 hr; distilling the extractive solution under reduced pressure, concentrating to 1.4-1.5g/ml, and spray drying;
(3) and (3) adding fructo-oligosaccharide, collagen peptide, maltodextrin and sucralose into the dried ginger extract and the momordica grosvenori extract, mixing the materials together and subpackaging.
Example 4
A solid beverage containing ginger and grosvenor momordica fruit is prepared from dried ginger extract 50 parts, grosvenor momordica fruit extract 20 parts, fructo-oligosaccharide 3.5 parts, collagen peptide 0.2 part, auxiliary material maltodextrin 30 parts, and sweetening agent sucralose 0.08 part.
The preparation method comprises the following steps:
(1) pulverizing Zingiberis rhizoma, adding 10 times volume of 75% ethanol, extracting at 50 deg.C for 4 hr, and distilling under reduced pressure to remove ethanol and water;
(2) pulverizing fructus Siraitiae Grosvenorii, adding 10 times of purified water, and extracting at 50 deg.C for 4 hr; distilling the extractive solution under reduced pressure, concentrating to 1.4-1.5g/ml, and spray drying;
(3) and (3) taking the dried ginger extract and the momordica grosvenori extract, adding fructo-oligosaccharide, collagen peptide, maltodextrin and sucralose, mixing, and subpackaging.
Example 5
A solid beverage containing ginger and momordica grosvenori is prepared from 60 parts of dried ginger extract, 35 parts of momordica grosvenori extract, 3.5 parts of fructo-oligosaccharide, 0.2 part of collagen peptide, 5 parts of auxiliary material maltodextrin and 0.08 part of sweetener sucralose.
The preparation method comprises the following steps:
(1) pulverizing Zingiberis rhizoma, adding 10 times volume of 75% ethanol, extracting at 50 deg.C for 4 hr, and distilling under reduced pressure to remove ethanol and water;
(2) pulverizing fructus Siraitiae Grosvenorii, adding 10 times of purified water, and extracting at 50 deg.C for 4 hr; distilling the extractive solution under reduced pressure, concentrating to 1.4-1.5g/ml, and spray drying;
(3) and (3) taking the dried ginger extract and the momordica grosvenori extract, adding fructo-oligosaccharide, collagen peptide, maltodextrin and sucralose, mixing, and subpackaging.
Example 6
The method is different from the embodiment 1 in that the grosvenor momordica fruit extract is subjected to macroporous resin chromatography column to enrich the grosvenor momordica fruit glycoside V, so as to obtain a grosvenor momordica fruit glycoside V crude product, and the grosvenor momordica fruit glycoside V crude product is used for replacing a grosvenor momordica fruit extract to prepare the ginger grosvenor momordica fruit solid beverage. In the crude product of the mogroside V, the content of the mogroside V is more than 65 percent.
Example 7
The difference from example 1 is that the weight ratio of extracts of zingiber and momordica grosvenori has an influence on the freezing tolerance time of the resulting solid beverage of zingiber and momordica grosvenori on kidney-yang-deficient rats by the following optimization method:
s11, preparing at least 3 ginger and momordica grosvenori solid beverages with different weights of the ginger and the momordica grosvenori according to the weight ratio of the extracts of the ginger and the momordica grosvenori, namely 1:1, 1.5:1, 2:1, 2.5:1, 3.5:1, 4:1 and 5: 1;
s12, starting from the first proportion, vectors X1 and X2 respectively represent the average degree of the freeze-resisting time of the ginger-momordica grosvenori solid beverage obtained by the extract proportions of two adjacent dried gingers and momordica grosvenori to rats with kidney-yang deficiency;
s22, calculating the stability of the vector using the following formula:
Wherein the content of the first and second substances,
s24, ifAnd if the weight ratio is more than 3.05, judging that the extract ratios of the two adjacent dried gingers and the momordica grosvenori have a significant difference, continuing to compare the next group by taking the second ratio as the start of the extract ratio of the two adjacent dried gingers and the momordica grosvenori until no significant difference exists, and taking the first weight ratio of the extract ratios of the two adjacent dried gingers and the momordica grosvenori as the optimal ratio.
By the method, the important influence factor of the proportion of the extracts of the dried ginger and the momordica grosvenori found in the preparation process can be optimized quickly and efficiently, the operation time is shortened, and the materials and the expenses are saved.
Comparative example 1
Ginger and momordica grosvenori solid beverage
The difference from the embodiment 1 is that the prepared raw materials comprise 50 parts of dried ginger extract, 3.5 parts of fructo-oligosaccharide, 0.2 part of collagen peptide, 50 parts of auxiliary material maltodextrin and 0.08 part of sweetener sucralose.
Comparative example 2
Ginger and momordica grosvenori solid beverage
The difference from the embodiment 1 is that the prepared raw materials comprise 50 parts of grosvenor momordica fruit extract, 3.5 parts of fructo-oligosaccharide, 0.2 part of collagen peptide, 50 parts of auxiliary material maltodextrin and 0.08 part of sweetener sucralose.
Experimental example 1 Effect on the Freeze-tolerant time of rats with Kidney Yang deficiency
Wistar rat, weight 200-;
injecting hydrocortisone into the abdominal cavity of a rat at the concentration of 25mg/kg for 10 days to construct a yang deficiency model;
the rats are fed with the solid beverage of the ginger, the momordica grosvenori and the solid beverage of the examples and the comparative examples respectively, and the rats are gavaged 1 time in the morning and at the evening, and each time is 1 mL. The dosage of each time is converted into 12g of ginger and fructus momordicae solid beverage per day for 60kg of adults. The rats were tested for freeze tolerance 4 weeks after gavage. Rats were placed in a constant temperature freezer at-10 ℃ and observed every 5 minutes for 1 time, and the survival time of the rats was recorded. The freezing tolerance time of the rats was calculated based on the negative control group of rats with stomach-perfused distilled water as 100%, and the results are shown in table 1.
TABLE 1 rat freezing tolerance time
In the same column of data, different lower case letters are marked to indicate that the difference is significant, and P is less than 0.05
The results show that the freeze-tolerant time of the rats in the kidney-yang deficiency model is significantly lower than that of the normal group, and the freeze-tolerant time of the groups of the comparative example 1 and the comparative example 2 is significantly lower than that of the examples 1 to 6. Example 6 is only slightly lower than examples 1-3, indicating that the crude mogroside V is the major active ingredient of Lo Han Guo extract. Examples 4 and 5 are significantly lower than examples 1-3, indicating that the weight ratio of Zingiberis rhizoma to Lo Han Guo affects the effect of the ginger Lo Han Guo solid beverage on kidney-yang deficient rats.
Experimental example 2 solid beverage sensory test of ginger and momordica grosvenori
The ginger and momordica grosvenori solid beverages of the examples and the comparative examples are brewed with 8 times of boiled water, and sensory evaluation is carried out according to a conventional method. The evaluation results are shown in Table 2, and the score results are shown in Table 3.
TABLE 2 sensory evaluation Table
TABLE 3 sensory evaluation score
Score of | |
Example 1 | 2 |
Example 2 | 2 |
Example 3 | 2 |
Example 4 | 3 |
Example 5 | 3 |
Example 6 | 1 |
Comparative example 1 | 5 |
Comparative example 2 | 1 |
In the same column of data, different lower case letters are marked to indicate that the difference is significant, and P is less than 0.05
The results show that comparative example 2 has a score of 1 because it has no components of Zingiberis rhizoma; comparative example 1 without luo han guo, scored 5; examples 1-3 are superior to examples 4 and 5, which show that the weight ratio of Zingiberis rhizoma to Siraitia grosvenorii affects the mouthfeel of the solid beverage.
While the preferred embodiments and examples of the present invention have been described in detail, the present invention is not limited to the embodiments and examples, and various changes can be made without departing from the spirit of the present invention within the knowledge of those skilled in the art.
Claims (10)
1. A solid beverage containing ginger and grosvenor momordica fruit is characterized in that the prepared raw materials at least comprise dried ginger and grosvenor momordica fruit or extracts thereof, and preferably further comprise fructo-oligosaccharide, collagen peptide and a sweetening agent.
2. The ginger-momordica grosvenori solid beverage according to claim 1, wherein the weight ratio of the dried ginger to the momordica grosvenori is (50-60): (20-35), preferably (50-55): (30-35).
3. The ginger-momordica grosvenori solid beverage according to claim 1 or 2, which is characterized by comprising the following raw materials in parts by weight:
50-60 parts of dried ginger extract, 20-35 parts of momordica grosvenori extract, 1-5 parts of fructo-oligosaccharide, 0.01-0.5 part of collagen peptide, 5-30 parts of auxiliary material maltodextrin and 0.05-0.2 part of sweetening agent.
4. The ginger-momordica grosvenori solid beverage according to claims 1 to 3, which is characterized by comprising the following raw materials in parts by weight:
the raw materials for preparation comprise 50-55 parts of dried ginger extract, 30-35 parts of momordica grosvenori extract, 2-4 parts of fructo-oligosaccharide, 0.1-0.3 part of collagen peptide, 10-20 parts of auxiliary material maltodextrin and 0.05-0.1 part of sweetening agent.
5. The solid beverage of zingiber officinale and momordica grosvenori as set forth in claims 1 to 4, wherein the extract of zingiber officinale is an ethanol extract of zingiber officinale.
6. The solid beverage of ginger momordica grosvenori according to claims 1 to 5, wherein the momordica grosvenori extract is a water extract of momordica grosvenori.
7. The solid beverage of ginger momordica grosvenori according to claims 1-6, wherein the momordica grosvenori extract is crude momordica grosvenori glycoside V.
8. A preparation method of the ginger-momordica grosvenori solid beverage according to any one of claims 1 to 7, which is characterized by comprising the following steps of:
s01, preparing a dried ginger extract;
s02, preparing a fructus momordicae extract;
s03, adding fructo-oligosaccharide, collagen peptide, maltodextrin and sucralose, mixing, and packaging.
9. The preparation method according to claim 8, wherein in S01, the dried ginger is pulverized, and then 70-80% ethanol is added in an amount of 5-15 times the volume of the pulverized dried ginger, and the pulverized dried ginger is extracted at 40-60 ℃ for 3-5 hours, and the ethanol and water are removed by distillation under reduced pressure.
10. The preparation method according to claim 8 or 9, wherein in S02, the momordica grosvenori is taken, pulverized, added with purified water in an amount of 5-15 times the volume of the pulverized momordica grosvenori, and extracted at 40-60 ℃ for 3-5 hours; distilling the extractive solution under reduced pressure, concentrating to 1.4-1.5g/ml, and spray drying.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202210642823.9A CN114868857A (en) | 2022-06-08 | 2022-06-08 | Ginger and momordica grosvenori solid beverage and preparation method thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202210642823.9A CN114868857A (en) | 2022-06-08 | 2022-06-08 | Ginger and momordica grosvenori solid beverage and preparation method thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
CN114868857A true CN114868857A (en) | 2022-08-09 |
Family
ID=82680393
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202210642823.9A Pending CN114868857A (en) | 2022-06-08 | 2022-06-08 | Ginger and momordica grosvenori solid beverage and preparation method thereof |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN114868857A (en) |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102771869A (en) * | 2012-08-16 | 2012-11-14 | 湖南千金养生坊健康品股份有限公司 | Collagen drink preparation and preparation method thereof |
CN111265650A (en) * | 2020-04-11 | 2020-06-12 | 刘神剑 | Novel traditional Chinese medicine composition and preparation method thereof |
-
2022
- 2022-06-08 CN CN202210642823.9A patent/CN114868857A/en active Pending
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102771869A (en) * | 2012-08-16 | 2012-11-14 | 湖南千金养生坊健康品股份有限公司 | Collagen drink preparation and preparation method thereof |
CN111265650A (en) * | 2020-04-11 | 2020-06-12 | 刘神剑 | Novel traditional Chinese medicine composition and preparation method thereof |
Non-Patent Citations (1)
Title |
---|
杨永利;郭守军;张雅珍;杨东娟;张振霞;: "罗汉果生姜饮料的加工工艺研究" * |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN104474438A (en) | Traditional Chinese medicine composition for promoting pig growth and improving pork quality | |
CN110215496A (en) | A kind of rhizoma polygonati processes formula and technique | |
CN111869874A (en) | Functional food with eucommia ulmoides and ginseng as main materials and application thereof | |
CN111990508A (en) | Essence-nourishing tea and preparation method thereof | |
CN112205557A (en) | Hypolipidemic solid food beverage and preparation method thereof | |
CN114868857A (en) | Ginger and momordica grosvenori solid beverage and preparation method thereof | |
CN111264672A (en) | Milk-flavored soft ice cream slurry and preparation method thereof | |
CN107279898A (en) | A kind of rose ginger jujube cream and preparation method thereof | |
CN105106592A (en) | Compound sweetener with traditional Chinese medicine extracts | |
CN109481578A (en) | A kind of compound surrogated tea and preparation method thereof | |
CN108041229A (en) | A kind of summer Traditional Chinese medicine health tea of invigorating spleen and nourishing heart | |
CN111773319A (en) | Medicinal and edible traditional Chinese medicine composition for conditioning yin-deficiency constitution and preparation method thereof | |
CN111686218A (en) | Medicinal and edible traditional Chinese medicine composition for conditioning qi-deficiency constitution and preparation method thereof | |
CN105639517A (en) | Loquat lotion and preparation method thereof | |
CN101869164A (en) | Bulbil skin nourishment tea | |
CN105168574A (en) | Healthcare maca oral solution and preparation method thereof | |
CN104651201A (en) | Vinegar for treating high blood pressure | |
CN105454750A (en) | Preparation method of sesame seed and honey syrup | |
CN109893619A (en) | A kind of Chinese medicine composition for treating parasite of human | |
CN110447875A (en) | A kind of preparation and production method nourishing goose chafing dish seasoning | |
CN110881659A (en) | Food for nourishing yin, conditioning physique and delaying senescence and preparation method thereof | |
CN113633736A (en) | Traditional Chinese medicine composition for treating hyperemesis gravidarum and preparation method thereof | |
CN115944039A (en) | Corn stigma and radix puerariae beverage | |
CN114258999A (en) | Functional beverage for invigorating kidney and strengthening yang and preparation method thereof | |
CN117180367A (en) | A Chinese medicinal composition for invigorating kidney and supporting yang, and its preparation method |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination |